Multiple Sclerosis Journal
The Multiple Sclerosis Journal (MSJ) – the sole official journal of ECTRIMS – is a peer-reviewed international journal that focuses on multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system.
- Biologic basis: pathology, myelin biology, the pathophysiology of the blood-brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics
- Epidemiology and genetics: genetics epigenetics, epidemiology
- Clinical and neuroimaging: clinical neurology, biomarkers, neuroimaging and clinical outcome measures
- Therapeutics and rehabilitation: therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management
This journal is a member of the Committee on Publication Ethics (COPE).
Now free to access:
Controversies in MS: a series of debates published regularly in the journal since October 2011. Read both sides of the debate on a wide range of key topics.
Topical reviews are also free to read in MSJ and are amongst MSJ’s most downloaded articles, these reviews are both succinct and up-to-date.
The President of ECTRIMS is co-editor of the Multiple Sclerosis Journal.
For further information please visit http://msj.sagepub.com.